2019
DOI: 10.1097/hjh.0000000000001898
|View full text |Cite
|
Sign up to set email alerts
|

Development of a novel aortic dissection mouse model and evaluation of drug efficacy using in-vivo assays and database analyses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
27
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 31 publications
(29 citation statements)
references
References 28 publications
2
27
0
Order By: Relevance
“…In a previous study, we reported that an increase in nitric oxide may upregulate the expression of the cell junction molecule, vascular endothelial cadherin, via ERK5 expression and protect the endothelium from vascular hyperpermeability [ 6 ]. Pitavastatin phosphorylates ERK5 directly and activates its downstream pathways including eNOS expression [ 6 ]. In the present study, we have showed that quercetin activated ERK5 to the same extent as pitavastatin ( Figure 4 ).…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…In a previous study, we reported that an increase in nitric oxide may upregulate the expression of the cell junction molecule, vascular endothelial cadherin, via ERK5 expression and protect the endothelium from vascular hyperpermeability [ 6 ]. Pitavastatin phosphorylates ERK5 directly and activates its downstream pathways including eNOS expression [ 6 ]. In the present study, we have showed that quercetin activated ERK5 to the same extent as pitavastatin ( Figure 4 ).…”
Section: Discussionmentioning
confidence: 99%
“…The mRNA expression levels in the aortas or culture cells were analyzed by real-time PCR, as described previously [ 6 ]. Sequences of the amplification primer pairs are as shown in Table 3 .…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations